adenosine has been researched along with Lung Diseases, Interstitial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armentano, A; Bilotta, F; Caracciolo, M; Caraglia, M; Conte, M; Correale, P; Cuzzola, M; De Lorenzo, A; Falcone, C; Falzea, AC; Foti, G; Iuliano, E; Macheda, S; Mangano, C; Morabito, A; Sitkovsky, M | 1 |
| Blackburn, MR; Schneider, DJ; Zhou, Y | 1 |
1 review(s) available for adenosine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Adenosine signaling and the regulation of chronic lung disease.
Topics: Acute Disease; Adenosine; Adenosine Deaminase; Animals; Chronic Disease; Disease Models, Animal; Humans; Lung Diseases, Interstitial; Lung Diseases, Obstructive; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction | 2009 |
1 other study(ies) available for adenosine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia.
Topics: Adenosine; Administration, Inhalation; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2 | 2020 |